Skip to main content
The Markets by Proactive
Go to Proactive UK
Proactive UK has moved. Proactive’s coverage of London’s small caps continues on proactiveinvestors.com Go there →
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Coverage of London’s small caps continues on proactiveinvestors.com
Go to Proactive UK
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK
Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK

Food & drink

FIVE at FIVE: Unilever’s ice cream split; AstraZeneca M&A; FTSE 100 flat; Robinhood tours London; Ted Baker administration

1. Unilever leaves Dutch ice cream float on the menu

“Where eventually the listing will take place as well as its head office, that’s something that we’re going to have to determine in the next 18 months,” Bloomberg quoted Unilever’s chief executive Hein Schumacher as saying.

Read more

2. AstraZeneca to buy Fusion Pharma in $2.4bln deal

At a price of $21 per share, the offer represents a 126% premium to Nasdaq-listed Fusion’s last closing price.

Read more

3. Robinhood tours City of London as trading app goes live in UK

Unlike the US offering, Robinhood UK users do not have access to cryptocurrency trading.

Read more

4. FTSE 100 closes higher

London's blue-chip index ended the day up 15 points at 7,735.

Read more

5. Ted Baker owner Authentic Brands calls in administrators after Dutch spat

Authentic Brands Group, which purchased Ted Baker for £211 million in 2022, said the damage was caused by AARC, which ran the brand's online and in-store operations in Europe up until January.

Read more

Advertisement
The Markets
by Proactive
Proactive UK has moved.
Small-cap coverage continues on .com
Go to Proactive UK